The World’s First Multi-Modality AI-Powered Worklist is Now Available to EU Hospitals via Zebra Medical Vision
Zebra Medical Vision (https://www.zebra-med.com/), the deep learning imaging analytics company, announces it’s been granted CE certification to two Zebra-Med products that accelerate clinical review and diagnosis of acute conditions in medical imaging. The AI technology can flag time-critical cases such as pneumothorax in chest x-rays and brain bleeds in CT scans. The technology reduces the time it takes radiologists and ER staff to spot acute conditions by 80%! This speed, in turn, improves the quality and timeliness of treatment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190228005326/en/
(Graphic: Zebra Medical Vision)
Zebra-med’s acute insights line of products is part of a growing list of solutions now offered to health providers and governments. The Zebra-Med imaging analytics engine connects to any PACS system and analyzes relevant scans with corresponding algorithms. Once an acute condition is detected, a standard HL7 message alerts the hospitals’ various systems, such as the radiology department or ER department worklists. Each hospital can customize the way the alert is presented in the worklist, either with color coding or priority ranking. The technology can be deployed on-premise or via the cloud, and neither method compromisess the radiology core workflow, originally acquired images, or risks breaching protected health information data laws.
Pneumothorax, the presence of gas within the pleural space between the lung and the chest wall, remains a globally important health problem with considerable associated morbidity and healthcare costs. Without prompt management, pneumothorax can lead to total lung collapse and other potentially fatal complications. It can be spontaneous or can be caused by underlying lung disease, trauma, or complications from biopsies or surgical procedures. With an estimated incidence rate of 18-28 cases per 100,000 population, there are between 130,000 - 207,000 cases of pneumothorax in Europe every year. Misdiagnosis or late-diagnosis of Pneumothorax impacts around 74,000 americans per year.
Brain bleed is even more prevalent and accounts for approximately 8-15% of all strokes in western countries. It impacts almost 3.6 million Americans each year. Strokes or traumatic brain injury occur every 9 seconds, and diagnostic brain scans can cost $150,000 per patient. Brain bleed is a devastating disease, with a high 30-day mortality rate that ranges from 35% to 52%. It is estimated that about 50% of this mortality occurs within the first 24 hours, emphasizing the importance of early detection and effective treatment in the Emergency Department.
“In a clinical validation study we performed, Zebra-med’s acute CXR pneumothorax and CT brain bleed products demonstrated a promising potential to substantially reduce turn around time and increase the radiologist's confidence in making these diagnoses,” said Dr. Terence Matalon, MD, FACR, FSIR Chairman, Diagnostic Radiology at Albert Einstein Medical Center. "Seeing the software in action emphasized key aspects AI solutions must address in order impact our field: high accuracy, speed, seamless integration to our workflow, and the ability to work on multi modalities - both X-ray and CT."
“Our acute-findings line of products emphasizes the Zebra Medical Vision team’s dedication to providing AI solutions to the majority of radiology departments worldwide who are reading and reporting more than just one modality,” says Eyal Gura, Zebra-Med’s CEO and Co-Founder. “We are thrilled to make this solution available today to hospitals across Europe that work with the many PACS and worklist systems that already integrate Zebra-Med’s software.”
Zebra-Med works with some of the world’s leading health providers, which together operate over 100 hospitals. Last year, Zebra-MEd received 8 CE marks for various algorithms and 510(k) FDA clearance for its Coronary Calcium Scoring algorithm, expanding company’s footprint in the US. In addition to the recently announced Israel Innovation Authority grants, Zebra-Med has raised over $50 million from a range of investors over three funding rounds.
*The acute-findings solutions are available for sale in the European Union, 510(k)-pending. Not available for sale in the USA.
Visit Zebra-Med’s blog.
About Zebra Medical Vision
Zebra Medical Vision uses deep learning to create and provide next generation products and services to the healthcare industry. Its Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease, and offer improved, preventative treatment pathways to improve patient care. Headquartered in Kibbutz Shefayim Israel, Zebra was founded in 2014 by Co-Founders Eyal Toledano, Eyal Gura, and Elad Benjamin and funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, J&J, and Dolby Ventures. For more information, visit www.zebra-med.com.
Blonde 2.0 for Zebra Medical Vision
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Key UK SEP Patent Win for TQ Delta20.3.2019 19:03:00 CET | Pressemelding
TQ Delta LLC, a technology development and licensing firm, secured a judgment on March 18 by the High Court of Justice of England and Wales immediately enjoining ZyXEL Communications UK Ltd and its Danish parent company, ZyXEL Communications A/S, from further infringement of TQ Delta's European Patent (UK) 1 453 268. TQ Delta's patent relates to Digital Subscriber Line ("DSL") technology. In an earlier judgment, handed down on March 12, the Court found that the patent was valid and essential to the operation of ADSL2 and VDSL2. In that judgment, the Court held that the ZyXEL defendants have infringed and continue to infringe the patent. The Court also found that a second patent would have also been essential and infringed but was invalid. In its judgment earlier this week, the Court also found that the ZyXEL defendants were "holding out" against taking a licence to TQ Delta's portfolio of patents relating to DSL. It granted an immediate injunction and costs against the ZyXEL defendants
Lehman Brothers Treasury Announces the Successful Auction of a Portion of its Intercompany Claim against Lehman Brothers Holdings Inc.20.3.2019 18:15:00 CET | Pressemelding
In connection with its previously announced partial wind-down, Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”), through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that its placement agent, Seaport Loan Products LLC, successfully concluded an auction of a US$10,475,844,413 portion of LBT’s US$34,548,000,000 intercompany claim (the “Intercompany Claim”) against Lehman Brothers Holdings Inc. for a total gross purchase price of US$179,472,166. The sale is expected to close during the first week of April 2019. The net proceeds of the sale (after deducting various sale-related costs and expenses), together with certain available cash, will be used to fund a final distribution to creditors of LBT who do not receive substitute notes as a result of LBT’s prior solicitation process. For more information on the partial wind-down, including information about the Intercompany Claim sale, the final cash distribution, and anticipated timelines, an Information Notice has
Susan Ochs Joins PSB as Global Head, Financial Services20.3.2019 17:34:00 CET | Pressemelding
PSB, a global research-based consultancy, announced today that Susan Ochs has joined the firm as Senior Vice President and Global Head, Financial Services, effective immediately. Ochs is based in New York and is responsible for the global development of the financial services practice and will contribute to other industry practices as well. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190320005671/en/ Susan Ochs, SVP, Global Head, Financial Services, PSB (Photo: Business Wire) “We are proud of the amazing brands we currently partner with across the financial sector,” said Mike Chuter, CEO, PSB, to whom Ochs reports. “With Susan’s combination of private and public finance expertise we’ll be able to deliver even more meaningful insights to our current and future partners. We are delighted to welcome Susan and are excited about the deep experience she brings.” Ochs has more than two decades of experience across the financial
Corsair Infrastructure Partners Announces Long Term Investments by HarbourVest Partners20.3.2019 14:35:00 CET | Pressemelding
Corsair Infrastructure Partners (“CIP”), the global infrastructure investment business of Corsair Capital (“Corsair”), today announced that HarbourVest Partners (“HarbourVest”), a leading institutional investor active across multiple asset classes and geographies, has invested in three new CIP-managed funds established to deploy capital in the aviation, port, and road sectors. Earlier this year, CIP’s new funds closed on the acquisitions of shareholdings in three platform companies – the airport developer Vantage Airport Group, the Australian stevedore DP World Australia, and the Spanish toll-road operator Itínere Infraestructuras – from various selling shareholders including Gateway Infrastructure Investments, a legacy CIP-managed vehicle. The investments from HarbourVest come from a long-term pool of institutional capital dedicated to supporting infrastructure equity sponsors like CIP, and will play an important role in the execution of CIP’s growth strategies for all three platforms
Fishawack continues to build best-in-class service offering with Dudnyk acquisition20.3.2019 13:00:00 CET | Pressemelding
Fishawack, a leading independent healthcare communications specialist, is excited to announce its acquisition of Dudnyk, the Philadelphia-based healthcare communications agency. Dudnyk is an award-winning, full-service agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They leverage strategic, scientific, and creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190320005204/en/ Dudnyk leadership team includes Christopher Tobias, PhD, President; Laurie Bartolomeo, EVP, Creative Director; Drew Desjardins, EVP, Chief Strategy Officer; Annemarie Armstrong, EVP, Director of Client Services; John Kemble, EVP, Creative Producer. (Photo: Business Wire) Fishawack’s goal is to increase the range of healthcare communications services that it can offer to commerc
ExaGrid Nominated in Six Categories for the 2019 Network Computing Awards20.3.2019 12:00:00 CET | Pressemelding
ExaGrid ®, a leading provider of intelligent hyperconverged storage for backup, today announced that it has been nominated in six categories for the 2019 Network Computing Awards. ExaGrid has become a finalist for Data Centre Product of the Year, The Return on Investment Award, Hardware Product of the Year, Product of the Year, The Customer Service Award, and Company of the Year. Voting to determine the winner in each category is underway now and closes on April 23. The results will be revealed at an evening award ceremony in London on May 2. ExaGrid’s model EX63000E backup storage appliance with data deduplication is a nominee in four categories. The model provides the largest scale-out system and offers up to a 2PB full backup with an ingest rate of 432TB/hr, which is three times faster than any other backup storage on the market. “We are thrilled to be nominated by IT staff, and recognized by Network Computing, in six prestigious categories this year,” said Bill Andrews, CEO and Pre